Valuation : H&R GmbH & Co. KGaA

Market Cap 267M 309M 252M 229M 429M 29.53B 431M 2.99B 1.15B 15.01B 1.16B 1.14B 47.24B P/E 2026 *
5.54x
P/E 2027 * 19.4x
Enterprise Value 289M 336M 274M 248M 465M 32.06B 468M 3.25B 1.25B 16.3B 1.26B 1.23B 51.29B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.2x
Free-Float
21.97%
Yield 2026 *
0.7%
Yield 2027 * 0.7%
08-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
16/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
26/03/25 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
1 day+0.85%
1 week+1.13%
Current month+5.29%
1 month+17.76%
3 months+53.98%
6 months+67.29%
Current year+66.90%
1 week 6.86
Extreme 6.86
7.2
1 month 5.86
Extreme 5.86
7.2
Current year 3.91
Extreme 3.91
7.2
1 year 3.91
Extreme 3.91
7.2
3 years 3.23
Extreme 3.23
7.2
5 years 3.23
Extreme 3.23
10.3
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%+1.13%+44.94%+47.33% 309M
-0.16%-2.30%+3.36%+20.83% 123B
-3.89%+3.99%+527.01%+245.36% 58.8B
+0.65%+0.73%-15.59%-44.67% 39.78B
-3.43%-4.07%+8.87%-21.27% 34.76B
-2.96%-1.76%+36.43%+65.31% 25.99B
-0.36%+3.94%+59.39%+377.00% 21.11B
-0.95%+0.27%+14.82%-36.51% 20.57B
-5.36%-5.42%+41.23%+10.21% 19.41B
-10.68%-7.95%+232.91%+470.54% 17.66B
Average -2.63%-0.58%+95.33%+113.41% 36.14B
Weighted average by Cap. -2.04%-0.82%+106.59%+88.27%

Financials

2026 *2027 *
Net sales 1.4B 1.62B 1.32B 1.2B 2.24B 155B 2.26B 15.68B 6.03B 78.6B 6.08B 5.94B 247B 1.36B 1.58B 1.29B 1.17B 2.19B 151B 2.2B 15.31B 5.89B 76.73B 5.93B 5.8B 241B
Net income 48.09M 55.77M 45.53M 41.26M 77.35M 5.33B 77.77M 540M 208M 2.71B 209M 205M 8.52B 13.79M 15.99M 13.05M 11.83M 22.18M 1.53B 22.3M 155M 59.58M 777M 60.06M 58.73M 2.44B
Net Debt 22.87M 26.52M 21.65M 19.62M 36.78M 2.53B 36.98M 257M 98.81M 1.29B 99.6M 97.39M 4.05B 8.65M 10.03M 8.19M 7.42M 13.91M 959M 13.99M 97.2M 37.38M 487M 37.68M 36.84M 1.53B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
11/09/26 €7.160 +0.85% 7,681
10/09/26 €7.100 -0.56% 14,479
09/09/26 €7.140 +1.42% 4,660
08/09/26 €7.040 -1.40% 1,788
07/09/26 €7.140 +0.85% 6,212
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.160EUR
Average target price
7.500EUR
Spread / Average Target
+4.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!